期刊文献+

Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting 被引量:3

Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting
下载PDF
导出
摘要 AIM: To synthesize dexamethasone-succinate-dextran(DSD) conjugate and to evaluate the potentiality of DSD forthe treatment of inflammatory bowel diseases.METHODS: Dexamethasone was attached to dextran(average molecular weight=70 400 Dalton) using succinateanhydride in an anhydrous environment catalyzed by 4-dimethylaminopyridine and 1, 1′-carbonyldiimidazole. Thechemical structure of DSD was identified by UV, IR and NMR,and the in vivo drug release behavior of this prodrug wasinvestigated after oral administration of DSD suspension.RESULTS: The DSD conjugate was obtained in two stepsand the content of dexamethasone in DSD was 11.28 %.The dextran prodrug was stable in rat stomach and smallintestine and negligibly absorbed from these tracts. Four tonine hours after the oral administration, most of the prodrug(>95 %) had moved to the cecum and colon, and was easilyhydrolyzed by an endodextranase. Recover ofdexamethasone from colon and cecum after administrationof DSD conjugate was 6-12 folds higher than the recoveryafter administration of unmodified dexamethasone(t=2.74,P<0.05). The preferential release of free dexamethasone incecum and colon over that in the small intestine wasstatistically significant (t=2.27, P<0.05).CONCLUSION: The results of this study indicate thatdextran conjugates may be useful in selectively deliveringglucocorticoids to the colon. AIM:To synthesize dexamethasone-succinate-dextran (DSD)conjugate and to evaluate the potentiality of DSD for the treatment of inflammatory bowel diseases. METHODS:Dexamethasone was attached to dextran (average molecular weight=70 400 Dalton)using succinate anhydride in an anhydrous environment catalyzed by 4- dimethylaminopyridine and 1,1'-carbonyldiimidazole.The chemical structure of DSD was identified by UV,IR and NMR, and the in vivo drug release behavior of this prodrug was investigated after oral administration of DSD suspension. RESULTS:The DSD conjugate was obtained in two steps and the content of dexamethasone in DSD was 11.28%. The dextran prodrug was stable in rat stomach and small intestine and negligibly absorbed from these tracts.Four to nine hours after the oral administration,most of the prodrug (>95%)had moved to the cecum and colon,and was easily hydrolyzed by an endodextranase.Recover of dexamethasone from colon and cecum after administration of DSD conjugate was 6-12 folds higher than the recovery after administration of unmodified dexamethasone(t=2.74, P<0.05).The preferential release of free dexamethasone in cecum and colon over that in the small intestine was statistically significant(t=2.27,P<0.05).CONCLUSION: The results of this study indicate that dextran conjugates may be useful in selectively delivering glucocorticoids to the colon.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第5期913-917,共5页 世界胃肠病学杂志(英文版)
基金 the National Distinguished Youth Scientific Fund,No.39925039
  • 相关文献

参考文献13

  • 1V. R. Sinha,Rachna Kumria.Colonic Drug Delivery: Prodrug Approach[J].Pharmaceutical Research.2001(5)
  • 2John M. Hebden,Clive G. Wilson,Robin C. Spiller,Peter J. Gilchrist,Elaine Blackshaw,Malcolm E. Frier,Alan C. Perkins.Regional Differences in Quinine Absorption from the Undisturbed Human Colon Assessed Using a Timed Release Delivery System[J].Pharmaceutical Research.1999(7)
  • 3Dawn A. Adkin,Carole J. Kenyon,E. Itzhack Lerner,Isaac Landau,Eric Strauss,David Caron,Adel Penhasi,Abraham Rubinstein,Ian R. Wilding.The Use of Scintigraphy to Provide ’Proof of Concept’ for Novel Polysaccharide Preparations Designed for Colonic Drug Delivery[J].Pharmaceutical Research.1997(1)
  • 4Cavalcanti OA,Van D,Caramico-Soares I,Kinget R.Polysaccharides as excipients for colon-specific coatings.Permeability and swelling properties of films[].Drug Development and Industrial Pharmacy.2002
  • 5Tozaki H,Fujita T,Komoike J,Kim SI,Terrashima H,Muranishi S,Okabe S,Yamamoto A.Colon-specific delivery of budesonide with a novel dodage form against 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats[].Journal of Pharmacokinetics and Pharmacodynamics.1999
  • 6Sangalli ME,Maroni A,Busetti C,Zema L,Giordano F,Gazzaniga A.In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs[].Bollettino Chimico Farmaceutico.1999
  • 7Tozaki H,Nishioka J,Komoike J,Okada N,Fujita T,Muranishi S,Kim SI,Terashima H,Yamamoto A.Enhanced absorption of insulin and (Asu(1,7) )el-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery[].Journal of Pharmacological Sciences.2001
  • 8Tozaki H,Fujita T,Odoriba T,Terabe A,Okabe S,Muranishi S,Yamamoto A.Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats[].Journal of Pharmacokinetics and Pharmacodynamics.1999
  • 9Goto M,Okamoto Y,Yamamoto M,Aki H.Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs[].Journal of Pharmacy and Pharmacology.2001
  • 10Ichinose K,Tomiyama N,Nakashima M,Ohya Y.Antitumor activity of dextran derivatives immobilizing platinum complex[].Anti Cancer Drugs.2000

二级参考文献21

共引文献217

同被引文献6

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部